David C. Smith
Impact in
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer survivorship and care
- Cancer Research top 0.5%
Papers in
- Oncology 131
- Cancer Treatment and Pharmacology 36
- Cancer Immunotherapy and Biomarkers 34
- Colorectal Cancer Treatments and Studies 16
-
- Prostate Cancer Treatment and Research 67
- Co-authors
- Kenneth J. Pienta (30 shared papers)Maha Hussain (40 shared papers)Marcus Ballinger (2 shared papers)Daniel S. Chen (2 shared papers)Keunchil Park (2 shared papers)Fadi Braiteh (2 shared papers)Achim Rittmeyer (2 shared papers)Alan Sandler (1 shared paper)
- Journals
- Journal of Clinical Oncology (109 papers)Cancer Chemotherapy and Pharmacology (18 papers)Cancer (14 papers)Investigational New Drugs (13 papers)Annals of Oncology (11 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
David C. Smith
408 papers receiving 16.7k citations
David C. Smith's Hit Papers
Peers
Comparison fields: 5 of 203
- Oncology 7.1k
- Cancer Research 1.9k
- Pulmonary and Respiratory Medicine 3.9k
- Immunology 1.8k
- Biological Psychiatry 207
Countries citing papers authored by David C. Smith
This map shows the geographic impact of David C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Smith more than expected).
Fields of papers citing papers by David C. Smith
This network shows the impact of papers produced by David C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Smith. The network helps show where David C. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside David C. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 426 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial Hit paper breakdown → | 2016 | 2139 |
| 2 | Five-Year Follow-Up of Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: Results From the CA209-003 Study Hit paper breakdown → | 2018 | 545 |
| 3 | Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab Hit paper breakdown → | 2019 | 424 |
| 4 | 2017 | 320 | |
| 5 | 2018 | 315 | |
| 6 | 1996 | 309 | |
| 7 | 2007 | 293 | |
| 8 | 2007 | 280 | |
| 9 | 2001 | 255 | |
| 10 | 2018 | 245 | |
| 11 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma Hit paper breakdown → | 2020 | 232 |
| 12 | 1987 | 207 | |
| 13 | 2010 | 202 | |
| 14 | 1992 | 187 | |
| 15 | 2007 | 180 | |
| 16 | 2007 | 180 | |
| 17 | 2017 | 176 | |
| 18 | 1998 | 174 | |
| 19 | Rapid ("warm") autopsy study for procurement of metastatic prostate cancer. | 2000 | 173 |
| 20 | 2008 | 165 |
About David C. Smith
David C. Smith is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Cancer Research, having authored 426 papers that have together received 17.3k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (67 papers), Bladder and Urothelial Cancer Treatments (46 papers), Cancer Treatment and Pharmacology (36 papers), Cancer Immunotherapy and Biomarkers (34 papers), Radiopharmaceutical Chemistry and Applications (19 papers), Urinary and Genital Oncology Studies (18 papers), Cancer Genomics and Diagnostics (17 papers) and Colorectal Cancer Treatments and Studies (16 papers). The work is most often cited by research in Oncology (7.1k citations), Cancer Research (1.9k citations), Pulmonary and Respiratory Medicine (3.9k citations), Immunology (1.8k citations) and Biological Psychiatry (207 citations). David C. Smith has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Kenneth J. Pienta, Maha Hussain, Marcus Ballinger, Daniel S. Chen, Keunchil Park, Fadi Braiteh, Achim Rittmeyer, Alan Sandler, Julien Mazières and Marcin Kowanetz. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Cancer, Investigational New Drugs and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.